Bellevue Life Sciences Acquisition Corp. (BLACU)
- Previous Close
10.75 - Open
0.00 - Bid --
- Ask --
- Day's Range
11.28 - 11.28 - 52 Week Range
10.09 - 11.28 - Volume
0 - Avg. Volume
9 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Bellevue Life Sciences Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The company intends to acquire companies in the healthcare industry. Bellevue Life Sciences Acquisition Corp. was founded in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.
--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: BLACU
Performance Overview: BLACU
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BLACU
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BLACU
Valuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-6.05%
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
403.78k
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
15.42k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
768.51k
Company Insights: BLACU
BLACU does not have Company Insights